Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 5. Respiratory tract infection.
Saito
A
A
The First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa.
Kawakami
K
K
Higa
F
F
D000818:Animals; D003453:Cryptococcosis / Q000188:drug therapy / Q000276:immunology; D016207:Cytokines / Q000502:physiology; D004198:Disease Susceptibility; D006801:Humans; D007371:Interferon-gamma / Q000502:physiology / Q000627:therapeutic use; D007378:Interleukins / Q000502:physiology / Q000627:therapeutic use; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000276:immunology; D016919:Meningitis, Cryptococcal / Q000188:drug therapy / Q000276:immunology; D051379:Mice; D009164:Mycobacterium Infections / Q000188:drug therapy / Q000276:immunology; D012141:Respiratory Tract Infections / Q000209:etiology* / Q000276:immunology; D018417:Th1 Cells / Q000276:immunology / Q000378:metabolism; D018418:Th2 Cells / Q000276:immunology / Q000378:metabolism
D016207:Cytokines; D007378:Interleukins; D007371:Interferon-gamma